Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$25.06 USD
+1.49 (6.32%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $25.02 -0.04 (-0.16%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
FLGT 25.06 +1.49(6.32%)
Will FLGT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FLGT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FLGT
Fulgent Genetics, Inc. (FLGT) Beats Q2 Earnings and Revenue Estimates
Fulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock?
FLGT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
Privia Health (PRVA) Misses Q4 Earnings Estimates
Other News for FLGT
Fulgent Genetics, Inc. (FLGT) Q2 2024 Earnings Call Transcript
Fulgent Reports Second Quarter 2024 Financial Results
Fulgent Genetics Inc (FLGT) Q2 2024 Earnings: EPS of ($0.29) Beats Estimates, Revenue of $71. ...
Fulgent Genetics Releases Updated Investor Presentation
Fulgent Genetics raises FY24 EPS view to (30c) from ($1.05), consensus (92c)